NCT02029521 - Supplementation of Oral Reduced Glutathione in Pediatric Cystic Fibrosis Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

July 31, 2012

Conditions

Cystic Fibrosis

Interventions

DIETARY_SUPPLEMENT

Oral reduced l-glutathione

The treatment was pharmaceutical-grade Reduced L-Glutathione (GSH) with a daily dose of 65 mg/kg. The placebo was calcium citrate with a daily dose of 65 mg/kg. The daily dose of each substance was divided into three doses given at mealtime.

DIETARY_SUPPLEMENT

Placebo

calcium citrate with a daily dose of 65 mg/kg. The daily dose of each substance was divided into three doses given at mealtime.

Trial Locations (1)

Unknown

Turin